Our ability to modulate p75 receptor levels by NGF exposure on a subset of metastatic melanoma cells that also renders the cells similar to non-metastatic cells and inhibits their ability to invade the embryonic neural crest microenvironment, suggests that we are selectively de-differentiating the stem cell population. The gene discussed is NGF; the disease is melanoma.